Developer docs
API playgroundTry for free, no card

Search company profiles

ProMED

Full company profile

uuid0038rk8

Namestring
ProMED
Legal namestring
ProMed, LLC
Websiteurl
gopromed.net
Company typeenum
Private
Founded yearstring
-
Descriptiontext

ProMED (legal entity ProMed, LLC) is a privately held medical device and diagnostic services company headquartered in Addison, Texas (Dallas metro area). The company's core business is the development, sale, and support of autonomic nervous system (ANS) diagnostic equipment sold to physician practices and medical clinics across the United States. Its product portfolio centers on three proprietary systems: the ProMed ANS BioScan System, which performs non-invasive Heart Rate Variability (HRV), blood pressure, and Pulse Wave Velocity analysis; the SudoCheck System, a sudomotor test for early detection of diabetic neuropathy and cardiometabolic risk; and the VitalScan ANS PWV Pro, an FDA 510(k) cleared and CE Marked comprehensive ANS testing platform backed by 30+ years of clinical research and a normative database of more than 50,000 assessments. All three products are positioned for early detection of autonomic dysfunction, cardiovascular autonomic neuropathy, and peripheral neuropathies, particularly in diabetic populations.

ProMED generates revenue through a mix of one-time hardware sales of diagnostic equipment, associated consumables, and recurring professional services. The company has expanded into adjacent service lines, including chronic wound care using amniotic membrane allografts (processed by Celularity under an FDA-regulated HCTP framework) delivered across clinic, assisted living, and home settings, as well as physician office-based allergy testing in the Dallas area. The go-to-market is sales-led, with direct outreach to physician practices supplemented by Medicare-compatible insurance billing support and revenue cycle management services that help practices integrate and monetize the diagnostic offerings. The company emphasizes practice revenue enhancement alongside clinical utility as a key value proposition.

Short descriptiontext

ProMED (ProMed, LLC) is a privately held Addison, TX medical device company that sells FDA 510(k)-cleared autonomic nervous system diagnostic equipment — including the BioScan, SudoCheck, and VitalScan ANS PWV Pro systems — to U.S. physician practices, and provides wound care and allergy testing services in the Dallas metro area.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
autonomic nervous system testing, medical diagnostic equipment, diabetic neuropathy detection, cardiovascular assessment devices, wound care solutions
Industry1 code
PRIMARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Diagnostic Equipment
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Equipment Sales
TypeOne Time License
Description

Sale of ANS diagnostic equipment including BioScan System and VitalScan ANS PWV Pro to physician practices and healthcare facilities.

gopromed.net
2Diagnostic Testing Solutions
TypeHardware Sales
Description

Provide customized testing platforms that enable physicians to diagnose autonomic nervous system disorders and peripheral neuropathies. Revenue generated through equipment sales and associated consumables.

gopromed.net
3Wound Care Treatments
TypeProfessional Services
Description

Chronic wound care treatment services using amniotic membrane allografts. Services provided in clinic, assisted living facilities, and at home settings.

gopromed.net
4Revenue Cycle Management Services
TypeProfessional Services
Description

Billing best practices and insurance claim support including Medicare billing codes, helping physician practices optimize reimbursement for diagnostic services.

gopromed.net
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

ProMED sells proprietary medical diagnostic equipment — including the ProMed ANS BioScan System, SudoCheck System, and VitalScan ANS PWV Pro — that enable physicians to perform non-invasive autonomic nervous system testing, diabetic neuropathy detection, and cardiovascular assessment. The company also provides wound care treatments using amniotic membrane allografts and supports practices with technical training, operational support, and Medicare-compliant billing guidance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Early detection of diabetic neuropathy before symptoms appear, when 5-year survival rates are significantly higher
+1 more record
Product overview1 text field

ProMED provides a portfolio of medical diagnostic solutions centered on autonomic nervous system testing and peripheral neuropathy detection. The core platform is the VitalScan ANS PWV Pro system, which serves as the primary testing platform, complemented by the ProMed ANS BioScan System for HRV and cardiovascular assessment, and the SudoCheck System for sudomotor function and diabetic neuropathy testing. The company also offers wound care services using amniotic membrane allografts and allergy testing services. All ANS testing devices are designed to enable early detection of autonomic dysfunction before symptoms appear.

Product and service1 record
1ProMed ANS BioScan System®
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Celularity processes the amniotic membrane allografts used in ProMED's wound care treatments. Placenta tissue is collected from approved donors and sent to Celularity labs for purification and processing. The allograft is regulated as a human cellular tissue product (HCTP) by FDA, and the facility is accredited by the American Association of Blood Banks (AABB).

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Organogenesis markets Apligraf and other advanced wound care biologics, competing directly with ProMED's amniotic membrane allograft wound care service in physician clinics and wound-care centers.

TypeBroad incumbent
Description

Philips provides cardiovascular and patient monitoring systems that can substitute for ProMED's HRV/PWV diagnostics as part of a broader diagnostic portfolio sold into hospitals and integrated delivery networks.

TypeDirect peer
Description

Itamar Medical (now part of ZOLL/ResMed) developed the EndoPAT system for endothelial function and autonomic assessment, directly competing with ProMED's BioScan/VitalScan HRV-based ANS diagnostics in physician-office cardiovascular autonomic testing.

TypeBroad incumbent
Description

Smith+Nephew's Advanced Wound Management portfolio overlaps with ProMED's wound-care service line as a broad incumbent offering dressings, NPWT, and biologics across hospital, clinic, and home-care settings.

TypeDirect peer
Description

MiMedx is a leading amniotic membrane allograft supplier for wound care, comparable to ProMED's Celularity-sourced wound-care allograft offering and a direct competitor for advanced chronic-wound treatment revenue.

TypeBroad incumbent
Description

GE Healthcare's patient monitoring and cardiology diagnostic suites (e.g., MAC ECG, CARESCAPE) compete with ProMED's electrophysiology-based ANS diagnostics at the integrated health-system buyer level.

TypeDirect peer
Description

Finapres produces non-invasive continuous blood pressure and cardiovascular monitoring equipment (Finapres NOVA), directly comparable to ProMED's blood pressure analysis and pulse wave velocity modules in ANS and cardiovascular diagnostics.

TypeDirect peer
Description

CNSystems manufactures the Task Force Monitor for continuous non-invasive hemodynamic and autonomic nervous system assessment, making it a direct peer to ProMED's BioScan/VitalScan ANS testing platform in physician and cardiology practices.

TypeBroad incumbent
Description

Welch Allyn (now part of Baxter) supplies physician-office diagnostic devices including vital signs monitors and ECG, representing the kind of broad incumbent ProMED competes against for the same primary-care budget.

TypeBroad incumbent
Description

Hologic operates in women's health and office-based diagnostics, an adjacent clinical footprint to ProMED's primary-care physician channels where ANS testing and specialty diagnostics share purchasing committees.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ProMED

Medical Diagnostic Equipmentgopromed.net

ProMED (ProMed, LLC) is a privately held Addison, TX medical device company that sells FDA 510(k)-cleared autonomic nervous system diagnostic equipment — including the BioScan, SudoCheck, and VitalScan ANS PWV Pro systems — to U.S. physician practices, and provides wound care and allergy testing services in the Dallas metro area.

What ProMED does

ProMED (legal entity ProMed, LLC) is a privately held medical device and diagnostic services company headquartered in Addison, Texas (Dallas metro area). The company's core business is the development, sale, and support of autonomic nervous system (ANS) diagnostic equipment sold to physician practices and medical clinics across the United States. Its product portfolio centers on three proprietary systems: the ProMed ANS BioScan System, which performs non-invasive Heart Rate Variability (HRV), blood pressure, and Pulse Wave Velocity analysis; the SudoCheck System, a sudomotor test for early detection of diabetic neuropathy and cardiometabolic risk; and the VitalScan ANS PWV Pro, an FDA 510(k) cleared and CE Marked comprehensive ANS testing platform backed by 30+ years of clinical research and a normative database of more than 50,000 assessments. All three products are positioned for early detection of autonomic dysfunction, cardiovascular autonomic neuropathy, and peripheral neuropathies, particularly in diabetic populations.

ProMED generates revenue through a mix of one-time hardware sales of diagnostic equipment, associated consumables, and recurring professional services. The company has expanded into adjacent service lines, including chronic wound care using amniotic membrane allografts (processed by Celularity under an FDA-regulated HCTP framework) delivered across clinic, assisted living, and home settings, as well as physician office-based allergy testing in the Dallas area. The go-to-market is sales-led, with direct outreach to physician practices supplemented by Medicare-compatible insurance billing support and revenue cycle management services that help practices integrate and monetize the diagnostic offerings. The company emphasizes practice revenue enhancement alongside clinical utility as a key value proposition.

ProMED firmographics

Firmographics
Name
ProMED
Legal name
ProMed, LLC
Website
https://gopromed.net
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
ProMED (ProMed, LLC) is a privately held Addison, TX medical device company that sells FDA 510(k)-cleared autonomic nervous system diagnostic equipment — including the BioScan, SudoCheck, and VitalScan ANS PWV Pro systems — to U.S. physician practices, and provides wound care and allergy testing services in the Dallas metro area.
Ownership category
akta.pro rank

ProMED industry classification

Industry
Product category
Medical Diagnostic Equipment
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

  • Autonomic nervous system testing
  • Medical diagnostic equipment
  • Diabetic neuropathy detection
  • Cardiovascular assessment devices
  • Wound care solutions

Where ProMED is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ProMED business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Medical Equipment Sales: Sale of ANS diagnostic equipment including BioScan System and VitalScan ANS PWV Pro to physician practices and healthcare facilities.
  2. Diagnostic Testing Solutions: Provide customized testing platforms that enable physicians to diagnose autonomic nervous system disorders and peripheral neuropathies. Revenue generated through equipment sales and associated consumables.
  3. Wound Care Treatments: Chronic wound care treatment services using amniotic membrane allografts. Services provided in clinic, assisted living facilities, and at home settings.
  4. Revenue Cycle Management Services: Billing best practices and insurance claim support including Medicare billing codes, helping physician practices optimize reimbursement for diagnostic services.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

ProMED product offering

Product offering

Core offering

ProMED sells proprietary medical diagnostic equipment — including the ProMed ANS BioScan System, SudoCheck System, and VitalScan ANS PWV Pro — that enable physicians to perform non-invasive autonomic nervous system testing, diabetic neuropathy detection, and cardiovascular assessment. The company also provides wound care treatments using amniotic membrane allografts and supports practices with technical training, operational support, and Medicare-compliant billing guidance.

Product overview

ProMED provides a portfolio of medical diagnostic solutions centered on autonomic nervous system testing and peripheral neuropathy detection. The core platform is the VitalScan ANS PWV Pro system, which serves as the primary testing platform, complemented by the ProMed ANS BioScan System for HRV and cardiovascular assessment, and the SudoCheck System for sudomotor function and diabetic neuropathy testing. The company also offers wound care services using amniotic membrane allografts and allergy testing services. All ANS testing devices are designed to enable early detection of autonomic dysfunction before symptoms appear.

Differentiator

Problem solved

Functional benefit

Products and services

  • ProMed ANS BioScan System®

Quantifiable outcome

  • Early detection of diabetic neuropathy before symptoms appear, when 5-year survival rates are significantly higher
  • +1 more outcomes

Companies that use ProMED

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles1 record

ProMED technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

ProMED partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CelularitycoreStrategic or Co-development PartnerCelularity processes the amniotic membrane allografts used in ProMED's wound care treatments. Placenta tissue is collected from approved donors and sent to Celularity labs for purification and processing. The allograft is regulated as a human cellular tissue product (HCTP) by FDA, and the facility is accredited by the American Association of Blood Banks (AABB).

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

ProMED competitors and assessment

Company assessment

Direct peers

  • Organogenesis: Organogenesis markets Apligraf and other advanced wound care biologics, competing directly with ProMED's amniotic membrane allograft wound care service in physician clinics and wound-care centers.
  • Itamar Medical: Itamar Medical (now part of ZOLL/ResMed) developed the EndoPAT system for endothelial function and autonomic assessment, directly competing with ProMED's BioScan/VitalScan HRV-based ANS diagnostics in physician-office cardiovascular autonomic testing.
  • MiMedx: MiMedx is a leading amniotic membrane allograft supplier for wound care, comparable to ProMED's Celularity-sourced wound-care allograft offering and a direct competitor for advanced chronic-wound treatment revenue.
  • Finapres Medical Systems: Finapres produces non-invasive continuous blood pressure and cardiovascular monitoring equipment (Finapres NOVA), directly comparable to ProMED's blood pressure analysis and pulse wave velocity modules in ANS and cardiovascular diagnostics.
  • CNSystems: CNSystems manufactures the Task Force Monitor for continuous non-invasive hemodynamic and autonomic nervous system assessment, making it a direct peer to ProMED's BioScan/VitalScan ANS testing platform in physician and cardiology practices.

Broad incumbents

  • Philips: Philips provides cardiovascular and patient monitoring systems that can substitute for ProMED's HRV/PWV diagnostics as part of a broader diagnostic portfolio sold into hospitals and integrated delivery networks.
  • Smith+Nephew (Advanced Wound Management): Smith+Nephew's Advanced Wound Management portfolio overlaps with ProMED's wound-care service line as a broad incumbent offering dressings, NPWT, and biologics across hospital, clinic, and home-care settings.
  • GE Healthcare: GE Healthcare's patient monitoring and cardiology diagnostic suites (e.g., MAC ECG, CARESCAPE) compete with ProMED's electrophysiology-based ANS diagnostics at the integrated health-system buyer level.
  • Welch Allyn (Baxter): Welch Allyn (now part of Baxter) supplies physician-office diagnostic devices including vital signs monitors and ECG, representing the kind of broad incumbent ProMED competes against for the same primary-care budget.
  • Hologic: Hologic operates in women's health and office-based diagnostics, an adjacent clinical footprint to ProMED's primary-care physician channels where ANS testing and specialty diagnostics share purchasing committees.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

ProMED social profiles

Digital presence

ProMED compliance and trust

Trust signal

Compliance4 records

ProMED financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ProMED leadership team

Management profile

Number of profiles

ProMED funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ProMED M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ProMED

What does ProMED do?

ProMED sells proprietary medical diagnostic equipment — including the ProMed ANS BioScan System, SudoCheck System, and VitalScan ANS PWV Pro — that enable physicians to perform non-invasive autonomic nervous system testing, diabetic neuropathy detection, and cardiovascular assessment. The company also provides wound care treatments using amniotic membrane allografts and supports practices with technical training, operational support, and Medicare-compliant billing guidance.

Is ProMED a public or private company?

ProMED is a private company. It is classified as unknown and is currently operating.

When was ProMED founded?

ProMED was founded in -1. It employs 1 to 10 people.

Where is ProMED based?

ProMED is headquartered in Dallas, United States, in the North America region.

How does ProMED make money?

Four revenue lines are on record. Medical Equipment Sales are the primary driver. The others are diagnostic Testing Solutions, wound Care Treatments and revenue Cycle Management Services.

Who are ProMED's main competitors?

Direct peers on record are Organogenesis, Itamar Medical, MiMedx, Finapres Medical Systems and CNSystems. Broad incumbents are Philips, Smith+Nephew (Advanced Wound Management), GE Healthcare, Welch Allyn (Baxter) and Hologic.

Does ProMED have an API?

No public API is recorded for ProMED.

What industry is ProMED in?

ProMED's product category is Medical Diagnostic Equipment. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales